Team:Berkeley/Safety

From 2013.igem.org

(Difference between revisions)
Line 8: Line 8:
<div class = "heading"><a name="Undergraduates">Safety Overview</a></div>
<div class = "heading"><a name="Undergraduates">Safety Overview</a></div>
 +
All of our team members were given a thorough safety training prior to the start of the iGEM program. UC Berkeley EH&S office (link to eh s) closely supervises research practices on campus, and our project was first approved by this office before its commencement.
<!-- DO NOT ERASE -->
<!-- DO NOT ERASE -->
**Safety forms were approved on 9/18/13 by David Lloyd and Julie McNamara. <br><br>
**Safety forms were approved on 9/18/13 by David Lloyd and Julie McNamara. <br><br>
<div class = "heading"><a name="EconomicalAnalysis">Chassis Organisms</a></div> <br />
<div class = "heading"><a name="EconomicalAnalysis">Chassis Organisms</a></div> <br />
-
 
+
<br> Our team worked only with the Escherichia Coli and Saccharomyces Cerevisiae species. E. coli K-12 is not considered a human or animal pathogen nor is it toxicogenic. Any concerns for E. coli K-12 in terms of health considerations are mitigated by its poor ability to colonize the colon and establish infections (http://epa.gov/oppt/biotech/pubs/fra/fra004.htm). S.cerevisiae is a GRAS organism (Generally recognized as Safe). Saccharomyces, as a genus, present low risk to human health or the environment. Criteria used to differentiate between species are based on their ability to utilize specific carbohydrates without relevance to pathogenicity (http://www.epa.gov/biotech_rule/pubs/fra/fra002.htm). Preventive measures such as sterilization of materials prior to disposal are in place to avoid any unforeseen risks. </br>
-
<br> Our team worked only with the Escherichia Coli and Saccharomyces Cerevisiae species. E. coli K-12 is not considered a human or animal pathogen nor is it toxicogenic. Any concerns for E. coli K-12 in terms of health considerations are mitigated by its poor ability to colonize the colon and establish infections (http://epa.gov/oppt/biotech/pubs/fra/fra004.htm). S.cerevisiae is a GRAS organism (Generally recognized as Safe). "Saccharomyces, as a genus, present low risk to human health or the environment. Criteria used to differentiate between species are based on their ability to utilize specific carbohydrates without relevance to pathogenicity." </br>(http://www.epa.gov/biotech_rule/pubs/fra/fra002.htm).
+
<div class = "heading"><a name="EconomicalAnalysis">Biobrick Part Safety</a></div> <br />
<div class = "heading"><a name="EconomicalAnalysis">Biobrick Part Safety</a></div> <br />
 +
We do not envision any of the parts we are using to be a safety concern in the lab. All of the parts we have cloned and expressed as well as their corresponding substartes and products have been documented previously by other authors. FMO's product, indigo, is known to be a low toxicity compound (LINKhttp://www.ncbi.nlm.nih.gov/pubmed/3598883) and many of the safety practices surrounding use of indigo have been well documented in the literature.
 +
<div class = "heading"><a name="EconomicalAnalysis">Dyeing with Indican - Safety</a></div> <br />
-
<div class = "heading"><a name="EconomicalAnalysis">Other Safety Concerns</a></div> <br />
+
In our envision dyeing process, indican would be the primary chemical that would coat jeans. Once indican was adhered to the jeans, our B-glucosidase would be added either as cell culture or purified enzyme to the jeans, which would then turn indican into indigo. Once the jeans have been sufficiently dyed, we have two priorities to ensure safety: removing any trace of bacteria from the cloth and removing indican. Indigo has already been proved to be safe to handle by both industry and labs. To remove both bacteria and indican, in the indican dyeing process, several rounds of washes in detergent as well as autoclaving the cloth would be ideal solutions. Because indican is soluble, it will wash off easily in detergent and water. E. Coli, the organism in which this biosynthetic dyeing pathway will be implemented, would also be killed by autoclaving because of the high temperatures (link of proof here). <br>
-
 
+
-
 
+
-
 
+
-
 
+
-
</ul>
+
-
</p>
+
-
 
+
-
<br><br>
+
-
<b> 2) Highest Risk Group Listed: 1 </b>
+
-
 
+
-
<br><br>
+
-
<b> 3) List and describe all new or modified coding regions you will be using in your project. (If you use parts from the 2013 iGEM Distribution without modifying them, you do not need to list those parts.)</b>
+
-
 
+
-
<p>
+
-
<ul>
+
-
<li> Part name: BBa_K1131000 <br>
+
-
<li> Where did you get the physical DNA for this part (which lab, synthesis company, etc): Synthesized, IDT <br>
+
-
<li> What species does this part originally come from?: Methylophaga aminisulfidivorans <br>
+
-
<li> What is the Risk Group of the species?: 1 <br>
+
-
<li> What is the function of this part, in its parent species?: Flavin-containing monooxygenase which hydroxylates indole. <br>
+
-
</ul>
+
-
+
-
<ul>
+
-
<li> Part name: BBa_K1131001_Glu <br>
+
-
<li> Where did you get the physical DNA for this part (which lab, synthesis company, etc): Synthesized, IDT <br>
+
-
<li> What species does this part originally come from?: Bacillus circulans <br>
+
-
<li> What is the Risk Group of the species?: 1 <br>
+
-
<li> What is the function of this part, in its parent species?: Beta-Glucosidase active on indican to produce indoxyl. <br>
+
-
</ul>
+
-
</p>
+
-
 
+
-
<b> 4) Do the biological materials used in your lab work pose any of the following risks? Please describe.</b>
+
-
<p>
+
-
<ul>
+
-
<li> Risks to the safety and health of team members or others working in the lab? <br>
+
-
<br> No known health risks posed by the materials used. Preventive measures such as PPE (Personal Protective Equipment) are in place to avoid any unforeseen risks. <br>
+
-
 
+
-
<li> Risks to the safety and health of the general public, if released by design or by accident? <br>
+
-
<br> No known health risks posed by the materials used. Preventive measures such as sterilization of materials prior to disposal are in place to avoid any unforeseen risks. <br>
+
-
 
+
-
<li> Risks to the environment, if released by design or by accident? <br>
+
-
<br>No known environmental risks posed by the materials used. All materials utilized have been studied extensively and are considered safe by all competent agencies. Preventive measures such as sterilization of materials prior to disposal are in place to avoid any unforeseen risks. <br>
+
-
 
+
-
<li>Risks to security through malicious misuse by individuals, groups, or countries? <br>
+
-
<br> No known security risks posed by the materials used. All materials utilized have been studied extensively and are considered safe by all competent agencies. Preventive measures such as sterilization of materials prior to disposal are in place to avoid any unforeseen risks. <br>
+
-
</ul>
+
-
</p>
+
-
</div>
+
-
</div>
+
-
 
+
-
 
+
-
 
+
-
<br>
+
-
<br>
+
-
<p>
+
-
 
+
-
<b> 5) . If your project moved from a small-scale lab study to become widely used as a commercial/industrial product, what new risks might arise? (Consider the different categories of risks that are listed in parts a-d of the previous question.) Also, what risks might arise if the knowledge you generate or the methods you develop became widely available?</b> </p>
+
-
 
+
-
<br>
+
-
<br>
+
-
<p>
+
-
 
+
-
<b> 6)  Does your project include any design features to address safety risks? </b></p>
+
-
 
+
-
<br>
+
-
<br>
+
-
<p>
+
-
 
+
-
<b> 7) What safety training have you received (or plan to receive in the future)? Provide a brief description, and a link to your institution’s safety training requirements, if available.</b> </p>
+
-
<br>
+
We followed our these outlined safety procedures in our own dyeing of lanyards with indican. We washed our lanyards with 5% SDS (a detergent) several times and then autoclaved the cotton material before washing again with 1% detergent water. <br>
-
<br>
+
-
<p>
+
-
<b> 8) Under what biosafety provisions will/do you work?</b> </p>
+
Scaling our process would present the added safety concerns of building and maintaining a bioreactor facility. Any facility meant to grow indican-producing and B-glucosidase producing bacteria as outlined on our Human Practices page would follow standard bioreactor design regulations as well as waste and operation regulations. <br>
-
</div>
+

Revision as of 21:49, 27 September 2013

All of our team members were given a thorough safety training prior to the start of the iGEM program. UC Berkeley EH&S office (link to eh s) closely supervises research practices on campus, and our project was first approved by this office before its commencement. **Safety forms were approved on 9/18/13 by David Lloyd and Julie McNamara.



Our team worked only with the Escherichia Coli and Saccharomyces Cerevisiae species. E. coli K-12 is not considered a human or animal pathogen nor is it toxicogenic. Any concerns for E. coli K-12 in terms of health considerations are mitigated by its poor ability to colonize the colon and establish infections (http://epa.gov/oppt/biotech/pubs/fra/fra004.htm). S.cerevisiae is a GRAS organism (Generally recognized as Safe). Saccharomyces, as a genus, present low risk to human health or the environment. Criteria used to differentiate between species are based on their ability to utilize specific carbohydrates without relevance to pathogenicity (http://www.epa.gov/biotech_rule/pubs/fra/fra002.htm). Preventive measures such as sterilization of materials prior to disposal are in place to avoid any unforeseen risks.

We do not envision any of the parts we are using to be a safety concern in the lab. All of the parts we have cloned and expressed as well as their corresponding substartes and products have been documented previously by other authors. FMO's product, indigo, is known to be a low toxicity compound (LINKhttp://www.ncbi.nlm.nih.gov/pubmed/3598883) and many of the safety practices surrounding use of indigo have been well documented in the literature.
In our envision dyeing process, indican would be the primary chemical that would coat jeans. Once indican was adhered to the jeans, our B-glucosidase would be added either as cell culture or purified enzyme to the jeans, which would then turn indican into indigo. Once the jeans have been sufficiently dyed, we have two priorities to ensure safety: removing any trace of bacteria from the cloth and removing indican. Indigo has already been proved to be safe to handle by both industry and labs. To remove both bacteria and indican, in the indican dyeing process, several rounds of washes in detergent as well as autoclaving the cloth would be ideal solutions. Because indican is soluble, it will wash off easily in detergent and water. E. Coli, the organism in which this biosynthetic dyeing pathway will be implemented, would also be killed by autoclaving because of the high temperatures (link of proof here).
We followed our these outlined safety procedures in our own dyeing of lanyards with indican. We washed our lanyards with 5% SDS (a detergent) several times and then autoclaved the cotton material before washing again with 1% detergent water.
Scaling our process would present the added safety concerns of building and maintaining a bioreactor facility. Any facility meant to grow indican-producing and B-glucosidase producing bacteria as outlined on our Human Practices page would follow standard bioreactor design regulations as well as waste and operation regulations.